J Krupicka
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
-
- Heart Failure Treatment and Management
- Cardiomyopathy and Myosin Studies
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Renin-Angiotensin System Studies
Papers in
-
- Acute Myocardial Infarction Research 5
- Blood Pressure and Hypertension Studies 3
- Cardiomyopathy and Myosin Studies 2
- Chemotherapy-induced cardiotoxicity and mitigation 1
- Cardiac Valve Diseases and Treatments 1
-
- Venous Thromboembolism Diagnosis and Management 4
- Co-authors
- P Gregor (3 shared papers)Martin Pěnička (2 shared papers)Karol Čurila (1 shared paper)Dan Marek (1 shared paper)Petr Widimský (4 shared papers)Michael Želı́zko (3 shared papers)Ladislav Groch (3 shared papers)Michael Aschermann (3 shared papers)
In The Last Decade
J Krupicka
19 papers receiving 422 citations
Peers
Comparison fields: 5 of 31
- Internal Medicine 143
- Cardiology and Cardiovascular Medicine 272
- Complementary and alternative medicine 16
- Endocrinology, Diabetes and Metabolism 13
- Emergency Medicine 5
Countries citing papers authored by J Krupicka
This map shows the geographic impact of J Krupicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Krupicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Krupicka more than expected).
Fields of papers citing papers by J Krupicka
This network shows the impact of papers produced by J Krupicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Krupicka. The network helps show where J Krupicka may publish in the future.
Co-authors
The 23 scholars most cited alongside J Krupicka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 127 | |
| 2 | 2020 | 89 | |
| 3 | 2008 | 68 | |
| 4 | 2019 | 36 | |
| 5 | Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). | 2003 | 35 |
| 6 | 2022 | 22 | |
| 7 | Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin's Lymphoma Study Group. | 2002 | 13 |
| 8 | 2026 | 9 | |
| 9 | 2003 | 8 | |
| 10 | 2023 | 8 | |
| 11 | Tumour necrosis factor-alpha soluble receptors type I are related to symptoms and left ventricular function in hypertrophic cardiomyopathy. | 2001 | 6 |
| 12 | 2024 | 5 | |
| 13 | 2026 | 5 | |
| 14 | [The efficacy and safety of moxonidine in patients with metabolic syndrome (the O.B.E.Z.I.T.A. trial)]. | 2011 | 4 |
| 15 | 2003 | 2 | |
| 16 | 2005 | 2 | |
| 17 | 2006 | 2 | |
| 18 | [Huge sinus of Valsalva aneurysm in patient with cystic medial necrosis of the aorta]. | 2004 | 1 |
| 19 | [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study]. | 2008 | 1 |
| 20 | 2003 | 0 |
About J Krupicka
J Krupicka is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 443 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Blood Pressure and Hypertension Studies (3 papers), Cardiomyopathy and Myosin Studies (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Cardiac Valve Diseases and Treatments (1 paper) and Cardiac Imaging and Diagnostics (1 paper). The work is most often cited by research in Internal Medicine (143 citations), Cardiology and Cardiovascular Medicine (272 citations), Complementary and alternative medicine (16 citations), Endocrinology, Diabetes and Metabolism (13 citations) and Emergency Medicine (5 citations). J Krupicka has collaborated with scholars based in Czechia and Germany. Frequent co-authors include P Gregor, Martin Pěnička, Karol Čurila, Dan Marek, Petr Widimský, Michael Želı́zko, Ladislav Groch, Michael Aschermann, František Bednář and Hana Línková. Their work appears in journals such as Journal of Thrombosis and Thrombolysis, JAMA, European Heart Journal, Journal of the American College of Cardiology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.